期刊文献+

特发性肺纤维化患者肺组织中窖蛋白-1和细胞外基质的表达 被引量:7

Expressions of caveolin-1 and extracellular matrix in lung tissues of patients with idiopathic pulmonary fibrosis
原文传递
导出
摘要 目的研究特发性肺纤维化(IPF)患者肺组织窖蛋白一1和细胞外基质表达的变化及其意义。方法6例IPF患者的肺组织标本来自2005年1月至2008年12月南京大学医学院附属鼓楼医院呼吸科住院患者,其开胸肺活检组织病理诊断符合普通型间质性肺炎。6例肺癌患者行肺叶切除,取其远离病变的肺组织标本作为对照组。用RT—PCR、Westernblot及免疫组织化学方法检测肺组织标本中的窖蛋白-1mRNA和蛋白表达。Westernblot检测肺组织标本的胶原-I、α-平滑肌肌动蛋白(α-SMA)和Smads蛋白表达。结果IPF患者肺组织窖蛋白-1的mRNA和蛋白表达(分别为0.05±0.02和0.16±0.05)明显低于对照组(分别为0.66±0.19和0.81±0.11),差异有统计学意义(F值分别为8.465和353.836,均P〈0.05)。IPF患者肺组织的胶原.I(0.85±0.11)和d—SMA蛋白(0.784-0.08)表达明显高于对照组(分别为0.164-0.04和0.14±0.05),差异有统计学意义(F值分别为485.09、410.027,均P〈0.05)。IPF患者肺组织的p-Smad2蛋白(0.78±0.08)和p-Smad3蛋白(0.86±0.07)表达明显高于对照组(分别为0.17±0.04和0.14±0.04),差异有统计学意义(F值分别为521.97和530.48,均P〈0.05);而Smad7蛋白表达(0.22±0.05)明显低于对照组(0.78±0.08),差异有统计学意义(F=414.84,P〈0.05)。结论IPF患者肺组织窖蛋白-1表达下调与特发性肺纤维化的发牛和发展有关。 Objective To investigate the expressions of caveolin-1, collagen- I , α-smooth muscle actin(α-SMA) and Smad in lung tissues of patients with idiopathic pulmonary fibrosis (IPF) and therefore to explore their potential roles in the pathogenesis of the disease. Methods Six patients with IPF confirmed pathologically by open lung biopsy in Department of Pulmonary Medicine, Affiliated Drum Tower Hospital of Nanjing University from January 2005 to December 2008 were studied. Diagnosis of IPF was made in accordance with the American Thoracic Society/European Respiratory Society Consensus Statement. At the same period, 6 normal lung samples were also obtained from patients with lung cancer by surgical resections as the control group. The level of caveolin-1 mRNA and protein, collagen- I , α-SMA and Smads in lung tissues were detected by RT-PCR, Western blot and immunohistochemistry. Results Compared with the control group, significantly reduced levels of caveolin-1 mRNA and protein (0. 66 ± 0. 19 vs 0. 05 ± 0. 02 ; 0. 81 ±0. 11 vs 0. 16 ±0. 05 ,P 〈0. 05) were observed in the lungs of patients with IPF. However, collagen-1 (0. 85 ±0. 11 vs 0. 16 ± 0.04) and ct-SMA(0. 78 ±0.08 vs 0. 14 ±0.05) proteins in the lung tissues of IPF patients were significantly increased as compared to the controls (P 〈 0. 05 ). The expressions of p-Smad2 and p-Smad3 proteins were significantly increased (0. 78 ±0. 08 vs 0. 17 ±0. 04;0. 86 ±0. 07 vs 0. 14 ±0. 04, respectively, P 〈0.05), while that of smad7 protein decreased (0. 22 ±0. 05 vs 0. 78 ±0. 08 ,P 〈0. 05) in the lungs of patients with IPF as compared with the control groups. Conclusion The reduced expression of caveolin-1 in lung tissues of IPF may be related to the development and progress of pulmonary fibrosis.
出处 《中华结核和呼吸杂志》 CAS CSCD 北大核心 2012年第5期336-339,共4页 Chinese Journal of Tuberculosis and Respiratory Diseases
基金 南京市医学科技发展重点项目(ZKX08023)
关键词 窖蛋白1 肺纤维化 SMAD蛋白质类 肌动蛋白类 胶原 Caveolin 1 Pulmonary fibrosis Smad proteins Actin Collagen
  • 相关文献

参考文献15

  • 1Selman M, Pardo A. The epithelial/fibroblastic pathway in the pathogenesis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol,2003, 29(3 Suppl) :S93-S97.
  • 2Selman M, King T E, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med, 2001, 134 : 136-151.
  • 3Rothberg KG, Heuser JE, Donzell WC, et al. Caveolin, a protein component of caveolae membrane coats. Cell, 1992, 68:673-682.
  • 4Cohen AW, Hnasko R, Schubert W, et al. Role of caveolae and caveolins in health and disease. Physiol Rev, 2004, 84: 1341- 1379.
  • 5Koslowski R, Barth K, Augstein A, et al. A new rat type I-like alveolar epithelial cell line R3/l: bleomycin effects on caveolin expression. Histochem Cell Bio1,200d, 121:509-519.
  • 6Kasper M, Reimann T, Hempel U, et al. Loss of caveolin expression in type I pneumocytes as an indicator of subcellular alterations during lung fibrogenesis. Histochem Cell Biol, 1998, 109:41-48.
  • 7Kasper M, Seidel L, Knels D, et al. Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdC12 and TGF- betal. Histochem. Cell Biol, 2004,121:131-140.
  • 8Odajima N, Betsuyaku T, Nasuhara Y, et al. Loss of caveolin-1 in bronchiolization in lung fibrosis. J Histochem Cytochem,2007, 55 : 899-909.
  • 9Xia H, Khalil W, Kahm J, et al. Pathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis. Am J Pathol, 2010, 176:2626-2637.
  • 10Hinz B, Phan SH, Thannickal VJ, et al. The myofibroblast: one function, multiple origins. Am J Pathol, 2007, 170 : 1807-1816.

二级参考文献30

  • 1Cohen AW,Hnasko R,Schubert W,et al.Role of caveolae and caveolins in health and disease.Physiol Rev,2004,84:1341-1379.
  • 2Bernatchez PN,Bauer PM,Yu J,et al.Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cell permeable peptides.Proc Natl Acad Sci U S A,2005,102:761-766.
  • 3Razani B,Woodman SE,Lisanti MP.Caveolae:from cell biology to animal physiology.Pharmacol Rev,2002,54:431-467.
  • 4Drab M,Verkade P,Elger M,et al Loss of caveolae,vascular dysfunction,and pulmonary defects in caveolin-1 gene-disrupted mice.Science,2001,293:2449-2452.
  • 5Murata T,Lin MI,Huang Y,et al.Reexpression of caveolin-1 in endothelium rescues the vascular,cardiac,and pulmonary defects in global caveolin-1 knockout mice.J Exp Med,2007,204:2373-2382.
  • 6American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.This joint statement of the American Thoracic Society (ATS),and the European Respiratory Society (ERS) was adopted by the ATS board of directors,June 2001 and by the ERS Executive Committee,June 2001.Am J Respir Crit Care Med,2002,165:277-304.
  • 7Selman M,Pardo A.Idiopathic pulmonary fibrosis:an epithelial/fibroblastic cross-talk disorder.Respir Res,2002,3:3.
  • 8Koslowski R,Barth K,Augstein A,et al.A new rat type I-like alveolar epithelial cell line R3/1:bleomycin effects on caveolin expression.Histochem Cell Biol,2004,121:509-519.
  • 9Kasper M,Seidel D,Knels L,et al.Early signs of lung fibrosis after in vitro treatment of rat lung slices with CdCl2 and TGF-betal.Histochem Cell Biol,2004,121:131-140.
  • 10Lasky JA,Brody AR.Interstitial fibrosis and growth factors.Environ Health Perspect,2000,108 Suppl 4:751-762.

共引文献4

同被引文献83

  • 1孔灵菲,康健.中华医学会第六届全国呼吸病学术会议纪要[J].中华结核和呼吸杂志,2004,27(12):858-861. 被引量:17
  • 2朱荣申,杨素封.噻奈普汀合并西地那非治疗抑郁伴性功能障碍[J].中国新药与临床杂志,2006,25(2):119-122. 被引量:6
  • 3王春雷,康健,李振华.还原型辅酶Ⅱ氧化酶蛋白亚单位在特发性肺纤维化患者中的表达[J].中华结核和呼吸杂志,2007,30(4):265-268. 被引量:5
  • 4李惠萍,黄建安,范峰,李霞,余慧,赵兰,何国钧.弥漫性肺疾病395例临床分析[J].上海医学,2007,30(9):665-668. 被引量:8
  • 5Cohen AW,Hnasko R,Schubert W. Role of caveolae and caveolins in health and disease[J].Physiological Reviews,2004,(04):1341-1379.doi:10.1152/physrev.00046.2003.
  • 6Jin Y,Lee SJ,Minshall RD. Caveolin-1:a critical regulator of lung injury[J].American Journal of Physiology-Lung Cellular and Molecular Physiology,2011,(02):L151–L160.
  • 7Lisanti MP,Scherer PE,Tang Z. Caveolae,caveolin and caveolin-rich membrane domains:a signaling hypothesis[J].Trends in Cell Biology,1994,(07):231-235.
  • 8Zhang M,Lin L,Lee SJ. Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways[J].American Journal of Physiology-Lung Cellular and Molecular Physiology,2009,(05):L945-L953.
  • 9Lv XJ,Li YY,Zhang YJ. Over-expression of caveolin-1 aggravate LPS-induced inflammatory response in AT-1 cells via up-regulation of cPLA2/p38 MAPK[J].Inflammation Research,2010,(07):531-541.
  • 10Sun Y,Hu G,Zhang X. Phosphorylation of caveolin-1 regulates oxidant induced pulmonary vascular permeability via paracellular and transcellular pathways[J].Circulation Research,2009,(07):676-685.

引证文献7

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部